Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | See Remarks | May 11, 2020 | May 13, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date May 11, 2020 · Filed May 13, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,308 |
Ending reported balance
After 2020-05-11 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-05-11 · Exercise / conversion · Acquired 276 · Balance 20,584 Row 2 · 2020-05-11 · Exercise / conversion · Acquired 827 · Balance 21,411 Row 3 · 2020-05-11 · Sale · Disposed 1,103 · Balance 20,308 F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 25, 2020. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.50 · Expires 2020-10-28 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-05-11 · Exercise / conversion · Disposed 276 · Balance 0 F2: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 28, 2013 date of grant until fully vested on October 28, 2016. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.22 · Expires 2021-01-27 | Direct | 0 |
Reported balance
After 2020-05-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-05-11 · Exercise / conversion · Disposed 827 · Balance 0 F3: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 25, 2020.
F2: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 28, 2013 date of grant until fully vested on October 28, 2016.
F3: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2020 Filed May 13, 2020 22:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 827 | $0.00 Strike: $60.22 | $0.00 |
DisclosureSEC source: 0001209191-20-028961 · doc4.xml · derivative · entry 5 Mori Janice Satsumi · CIK 0001795849 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 827 shares Expires 2021-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 27, 2014 date of grant until fully vested on January 27, 2017. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 276 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001209191-20-028961 · doc4.xml · derivative · entry 4 Mori Janice Satsumi · CIK 0001795849 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 276 shares Expires 2020-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 28, 2013 date of grant until fully vested on October 28, 2016. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,103 | $67.14 | $74,055.42 |
DisclosureSEC source: 0001209191-20-028961 · doc4.xml · nonDerivative · entry 3 Mori Janice Satsumi · CIK 0001795849 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,308 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 25, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 827 | $60.22 | $49,801.94 |
DisclosureSEC source: 0001209191-20-028961 · doc4.xml · nonDerivative · entry 2 Mori Janice Satsumi · CIK 0001795849 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 276 | $46.50 | $12,834.00 |
DisclosureSEC source: 0001209191-20-028961 · doc4.xml · nonDerivative · entry 1 Mori Janice Satsumi · CIK 0001795849 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 21:51 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 4,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-060051 · doc4.xml · nonDerivative · entry 1 Mori Janice Satsumi · CIK 0001795849 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,308 F1 · shares: One-third of the restricted stock units will vest on October 31, 2020, and one-third of the restricted stock units will vest each year thereafter on October 31, such that the entire award will be fully vested on October 31, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.